SBIR/STTR Research Award

Interaction between islets and implantable immunoisolation polyurethane membranes

Award identifier 924a5b0134bd3440060f6e58e3fc1912355d4fd353d303cdc3f03142e0d2c22fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
RST IMPLANTED CELL TECHNOLOGY, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The development of bio-artificial organs (sequestered cell cultures, implanted within an isolating membrane) is complicated by many dynamic and interrelated variables. One major variable is the relationship between the cell cultures contained in the membrane and the membrane, which will have a direct impact on the ability of the sequestered chamber to provide the desired therapeutic effects. This Phase 1 SBIR grant application will result in the development of methods to be used for mechanically segregating pancreatic islets clusters or ? cells within a membrane chamber. The first specific aim of this grant is to test the feasibility of mechanically separating islets harvested from neonatal rats within an isolating membrane during in-vitro cell culture experiments. The second aim of this grant is to determine the adhesion properties between?? cells in culture with a laminin coated polyurethane membrane. The third aim of this grant is to compare the insulin production from islet clusters that have been segregated by mechanical means (specific aim 1) to insulin production from beta cells that have been individually stabilized by adhesion to the laminin coated membrane (specific aim 2). The results from this Phase I project will directly impact the specific design criteria of a clinically useful cell chamber device. The information gained by studying the interactions between islets,??-cells, the polyurethane membrane and surface modification using laminin will provide essential insight into the structure, dimensions and capacity of a larger medical device used for the treatment of type -1 diabetes. It is our intention to pursue the specific device development in concert with a Phase II grant application in conjunction with other corporate collaborations.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.